Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 13701 - 13725 of 14636 in total

(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine

Experimental

N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide

Experimental

4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose

Experimental

Allosamizoline

Experimental

1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID

Experimental

(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one

Experimental

ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE

Experimental

Thienylfentanyl

Thienylfentanyl is a fentanyl analog analgesic that was sold on the black market in the 1980s until the Federal Analog Act scheduled drugs based on structural similarity rather than scheduling drugs individually. Thienylfentanyl has a similar synthesis pathway to fentanyl except 2-(2-bromoethyl)thiophene is substituted for phenethyl bromide.
Illicit

Naveglitazar

Naveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent.
Investigational

LG-100268

LG-100268 is a retinoid X receptor (RXR) selective compound.
Experimental

5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine

Experimental

1h-Benoximidazole-2-Carboxylic Acid

Experimental

7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide

Experimental

2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium

Experimental

4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One

Experimental

SB220025

Experimental

1-Naphthyl-L-alanine

Experimental

3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine

Experimental

3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL

Experimental

2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE

Experimental

CERC-301

Mk 0657 has been used in trials studying the treatment of Major Depressive Disorder.
Investigational

MK-6186

MK6186 has been used in trials studying the treatment of HIV-1 Infection.
Investigational

Ethadione

Experimental

AT9283

AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer. It was discovered and developed internally using Astex’s fragment-based drug discovery platform, Pyramid.
Investigational
Matched Description: … It was discovered and developed internally using Astex’s fragment-based drug discovery platform, Pyramid …

Verubulin

Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
Investigational
Displaying drugs 13701 - 13725 of 14636 in total